Publications

You can use the filters to show only results that match your interests

Filter publications
334 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Suspended and revoked licences for manufacturers and wholesalers of medicines

  2. Advertising investigations: April 2017

    • MHRA
    • Decision
  3. Marketing authorisations granted in April 2017

  4. Parallel import licences granted in April 2017

  5. Early access to medicines scheme (EAMS) scientific opinion: Glecaprevir/Pibrentasvir for the treatment of chronic hepatitis C (HCV) infection in adults

  6. Early access to medicines scheme applications: pending, refused, granted

    • MHRA
    • Official Statistics
  7. Human and veterinary medicines: register of licensed manufacturing sites 2017

  8. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  9. Human and veterinary medicines: register of licensed wholesale distribution sites

  10. Medicines: new manufacturing and wholesale dealer licences

  11. Register of brokers authorised to deal in human medicines

  12. Medicines: licensing time-based performance measures

    • MHRA
    • Official Statistics
  13. Advertising investigations: March 2017

  14. Medicines and Healthcare products Regulatory Agency spending over £25,000: 2016 to 2017

    • MHRA
    • Transparency data
  15. Drug Safety Update: monthly PDF newsletter

    • MHRA
    • Guidance
  16. Medical devices: software applications (apps)

  17. Medicines and Healthcare products Regulatory Agency Business Plan 2017 to 18

    • MHRA
    • Corporate report
  18. Good manufacturing practice inspection deficiencies

    • MHRA
    • Official Statistics
  19. MHRA: policy for handling conflicts of interest

    • MHRA
    • Corporate report
  20. Patient group directions (PGDs)

    • MHRA
    • Guidance
  21. Parallel import licences granted in March 2017

  22. Marketing authorisations granted in March 2017

  23. Clinical trials for medicines: authorisation assessment performance

    • MHRA
    • Transparency data
  24. Toolkit on the risks of valproate medicines in female patients

  25. MHRA fees

    • MHRA
    • Statutory guidance
  26. Common issues identified during clinical trial applications

    • MHRA
    • Guidance
  27. Proposal to make Dovonex Psoriasis Ointment available from Pharmacies

    • MHRA
    • Closed consultation
  28. Medical devices: Virtual Manufacturing replaces Own Brand Labelling

  29. Proposal to make Sildenafil 50mg film-coated tablets available from Pharmacies

    • MHRA
    • Closed consultation
  30. Final report: Use, safety and efficacy of transvaginal mesh implants in the treatment of stress urinary incontinence and pelvic organ prolapse in women

    • MHRA
    • Independent report
  31. Medical devices regulations: compliance and enforcement

  32. Annual review of good clinical practice referrals: 2011 to 2016

  33. Proposal to make Maloff Protect 250mg/100mg film-coated tablets available from Pharmacies

    • MHRA
    • Closed consultation
  34. Parallel import licences granted in February 2017

  35. Marketing authorisations granted in February 2017

  36. Early access to medicines scheme (EAMS) scientific opinion: Dupilumab for treatment of dermatitis

  37. Leadless cardiac pacemaker therapy:new guidance from an MHRA Expert Advisory Group

    • MHRA
    • Guidance
  38. Herbal medicines granted a traditional herbal registration (THR)

  39. Blood bank compliance report template

    • MHRA
    • Form
  40. Blood facility declaration form

    • MHRA
    • Form